✦ LIBER ✦

A phase II study of CI-973 [SP-4-3(R)]- [1, 1-cyclobutane-dicarboxylato (2-)] (2-methyl-1,4-butanediamine-N, N′) platinum in patients with refractory advanced breast cancer

✍ Scribed by R. L. Theriault, Ronald S. Walters…

Book ID: 120776658
Publisher: Springer
Year: 1996
Tongue: English
Weight: 119 KB
Volume: 38
Category: Article
ISSN: 0344-5704
DOI: 10.1007/s002800050484

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Synthesis of the anti-tumor agent CI-973

Synthesis of the anti-tumor agent CI-973 {[SP-4-3-(R)]-[1,1-cyclobutanedicarboxylato(2)](2-methyl-1,4-[4-14C]butanediamine-N,N′)platinum}

✍ I. Victor Ekhato; James D. Hoeschele; Che C. Huang; Bela Nanavaty; Helen T. Lee 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 French ⚖ 307 KB 👁 1 views

## Abstract Starting from the chiral compound 1, (R)‐(+)‐2‐methyl‐1,4‐[^14^C]butanediamine 7 was synthesized in a sequence of reactions in which ^14^C‐label was introduce using label potassium cyanide. Compound 7 was reacted with potassium tetraiodoplatinate and silver 1,1‐cyclobutanedicarboxylate

Phase I clinical evaluation of [SP-4-3(R

Phase I clinical evaluation of [SP-4-3(R)]-[1,1-cyclobutanedicarboxylato(2-)](2-methyl-1,4-butanediamine-N,N1) platinum in patients with metastatic solid tumors

✍ Richard L. Theriault; I. A. Cohen; Laura Esparza; C. Kowal; Martin N. Raber 📂 Article 📅 1993 🏛 Springer 🌐 English ⚖ 437 KB

A Phase I study of cis-malonato[(4R,5R)-

A Phase I study of cis-malonato[(4R,5R)-4,5-bis(aminomethyl)-1,3-dioxolane] platinum(II) in patients with advanced malignancies

✍ Noe Kyeong Kim; Tae-You Kim; Sang-Goo Shin; Young Iee Park; Jung Ae Lee; Yong-Ba 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 122 KB 👁 1 views

Phase I trial of MDXH210 (FeγRI×HER-2/ne

Phase I trial of MDXH210 (FeγRI×HER-2/neu, bispecific antibody) in combination with G-CSF in patients with metastatic breast cancer: H. van Ojik1, G. Groenewegen1, R. Repp3, T. Valerius3, A. van Oers2, N.A.C. Westerdaal2, Y. Deo4, G.H. Blijham1, J.G.J. van de Winkel2. Departments of Internal Medicine1 and Immunology2, University Hospital, Utrecht, Netherlands, Department of Medicine III, University of Erlangen-Nurnberg3, with Germany, support from Medarex4, Annandale, NJ, USA

📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 110 KB